Ocugen, Inc. financial data

Symbol
OCGN on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11 Great Valley Parkway, Malvern, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
HISTOGENICS CORP (to 9/26/2019)
Latest financial report
10-K - Q4 2024 - Mar 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 212 % -27.8%
Debt-to-equity 102 % +98%
Return On Equity -184 % -56.5%
Return On Assets -91.3 % -17.5%
Operating Margin -1.35K % -24.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 292M shares +13.5%
Common Stock, Shares, Outstanding 291M shares +13.6%
Entity Public Float 393M USD +186%
Common Stock, Value, Issued 2.92M USD +13.6%
Weighted Average Number of Shares Outstanding, Basic 257M shares +7.99%
Weighted Average Number of Shares Outstanding, Diluted 257M shares +7.99%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.06M USD -32.8%
General and Administrative Expense 26.7M USD -16.6%
Operating Income (Loss) -54.8M USD +16.4%
Nonoperating Income (Expense) 703K USD -71.3%
Net Income (Loss) Attributable to Parent -54.1M USD +14.3%
Earnings Per Share, Basic -0.17 USD/shares +56.4%
Earnings Per Share, Diluted -0.17 USD/shares +56.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.7M USD -77.8%
Assets, Current 61.7M USD +43.5%
Property, Plant and Equipment, Net 16.6M USD -4.26%
Operating Lease, Right-of-Use Asset 3.61M USD -8.39%
Other Assets, Noncurrent 3.9M USD -9.03%
Assets 82.4M USD +27.7%
Accounts Payable, Current 4.24M USD +33.8%
Employee-related Liabilities, Current 2.43M USD +35.8%
Liabilities, Current 21.6M USD +26.3%
Operating Lease, Liability, Noncurrent 3.31M USD -7.12%
Other Liabilities, Noncurrent 564K USD +7.02%
Liabilities 52.8M USD +120%
Accumulated Other Comprehensive Income (Loss), Net of Tax 48K USD +140%
Retained Earnings (Accumulated Deficit) -340M USD -18.9%
Stockholders' Equity Attributable to Parent 29.6M USD -27%
Liabilities and Equity 82.4M USD +27.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD +41.9%
Net Cash Provided by (Used in) Financing Activities -145K USD -103%
Net Cash Provided by (Used in) Investing Activities -2.35M USD -168%
Common Stock, Shares Authorized 390M shares 0%
Common Stock, Shares, Issued 291M shares +13.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -13.1M USD -40.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 58.8M USD +49.1%
Deferred Tax Assets, Valuation Allowance 120M USD +6.41%
Deferred Tax Assets, Gross 121M USD +6.34%
Operating Lease, Liability 3.83M USD -7.46%
Payments to Acquire Property, Plant, and Equipment 2.35M USD +45.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -54M USD +14.4%
Lessee, Operating Lease, Liability, to be Paid 5.21M USD -10.7%
Property, Plant and Equipment, Gross 19.7M USD +6.45%
Operating Lease, Liability, Current 519K USD -9.58%
Lessee, Operating Lease, Liability, to be Paid, Year Two 894K USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 877K USD +11.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.37M USD -18.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 867K USD +3.83%
Deferred Tax Assets, Operating Loss Carryforwards 67.8M USD +16.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 303K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 884K USD +3.03%
Additional Paid in Capital 367M USD +13.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 901K USD -1.85%
Share-based Payment Arrangement, Expense 7.43M USD -19.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%